Oxytocin analogs with oxygen-containing side chains in position 3

Area of Science:

• Peptide Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Oxytocin analogs are crucial for understanding peptide hormone function.
• Modifications to the amino acid side chain can significantly alter biological activity.
• Investigating structure-activity relationships is key to developing targeted therapeutics.

Purpose of the Study:

• To synthesize and characterize three novel oxytocin analogs.
• To investigate the impact of increased side chain length and hydrophilicity on analog potency and specificity.
• To elucidate the influence of oxygen atom placement within the side chain on biological activities.

Main Methods:

• Synthesis of three oxytocin analogs: [3-O-methylhomoserine] oxytocin, [3-O-ethylserine] oxytocin, and [3-O-methylthreonine] oxytocin.
• In vitro and in vivo assays to determine milk ejection, uterine, antidiuretic, and pressor activities.
• Comparative analysis of analog activities based on structural modifications.

Main Results:

• Longer side chains, as seen in [3-O-methylhomoserine] and [3-O-ethylserine] oxytocin, generally increased all tested activities.
• Moving the hydrophilic oxygen atom further from the peptide backbone decreased vasopressin-like activities.
• This structural modification increased or had no effect on oxytocin-like activities, such as milk ejection and uterine contraction.

Conclusions:

• Side chain length is a critical determinant of oxytocin analog potency.
• The position of the hydrophilic oxygen atom influences selectivity between oxytocin and vasopressin receptor activities.
• These findings provide valuable structure-activity relationship data for the rational design of oxytocin-based therapeutics.